Expert-authored slides on the latest approaches to HIV prevention. Topics include epidemiology of PrEP uptake, current PrEP options and recommendations, and the latest data on next generation PrEP innovations, including long-acting injectable PrEP and vaginal rings.
Expert-authored slides on the collision of HIV and COVID-19, including the impact of HIV infection on COVID-19 risk and disease severity and the impact of COVID-19 on access to HIV care.
Expert-authored slides on evolving ART concepts, including simplification to 2-drug therapy, ART safety during pregnancy, weight gain, and long-acting injectable ART.
Expert-authored slides on implementing the 4 strategies of the Ending the HIV Epidemic initiative: diagnose, treat, prevent, and respond.
As we approach the halfway point for the 10-year goal of increasing PrEP use 50% by 2025, how are we doing? Here’s my take.
In this engaging panel discussion from the CCO HIV annual meeting, experts examine the latest advances in antiretroviral therapy, including simplification to 2-drug regimens, ART safety in pregnancy, ARV-associated weight gain, and forthcoming innovations.
Watch this dynamic panel discussion from the CCO HIV annual meeting on the plan for ending the US HIV epidemic, from early diagnosis through rapid response to potential outbreaks.